These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Con: Tight glucose control after brain injury is unproven and unsafe. Yoder J J Neurosurg Anesthesiol; 2009 Jan; 21(1):55-7. PubMed ID: 19098626 [No Abstract] [Full Text] [Related]
6. The prognostic value of hyperglycemia in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. Shi M; Zhang TB; Li XF; Zhang ZY; Li ZJ; Wang XL; Zhao WY Neurosurg Rev; 2022 Dec; 45(6):3717-3728. PubMed ID: 36169785 [TBL] [Abstract][Full Text] [Related]
7. Insulin-related decrease in cerebral glucose despite normoglycemia in aneurysmal subarachnoid hemorrhage. Schlenk F; Graetz D; Nagel A; Schmidt M; Sarrafzadeh AS Crit Care; 2008; 12(1):R9. PubMed ID: 18218076 [TBL] [Abstract][Full Text] [Related]
9. [Relevance of hyperglycemia on the course and outcome of aneurysmal subarachnoid hemorrhage: evidence and mechanisms]. Pérez-Neri I Invest Clin; 2014 Sep; 55(3):278-88. PubMed ID: 25272527 [TBL] [Abstract][Full Text] [Related]
10. Impact of hyperglycemia on neurological deficits and extracellular glucose levels in aneurysmal subarachnoid hemorrhage patients. Kerner A; Schlenk F; Sakowitz O; Haux D; Sarrafzadeh A Neurol Res; 2007 Oct; 29(7):647-53. PubMed ID: 18173901 [TBL] [Abstract][Full Text] [Related]
11. Hyperglycemia and clinical outcome in aneurysmal subarachnoid hemorrhage: a meta-analysis. Kruyt ND; Biessels GJ; de Haan RJ; Vermeulen M; Rinkel GJ; Coert B; Roos YB Stroke; 2009 Jun; 40(6):e424-30. PubMed ID: 19390078 [TBL] [Abstract][Full Text] [Related]
12. Risk Factors for Delayed Cerebral Ischemia in Good-Grade Patients With Aneurysmal Subarachnoid Hemorrhage. Rautalin I; Juvela S; Martini ML; Macdonald RL; Korja M J Am Heart Assoc; 2022 Dec; 11(23):e027453. PubMed ID: 36444866 [TBL] [Abstract][Full Text] [Related]
14. Treating hyperglycemia in neurocritical patients: benefits and perils. Godoy DA; Di Napoli M; Rabinstein AA Neurocrit Care; 2010 Dec; 13(3):425-38. PubMed ID: 20652767 [TBL] [Abstract][Full Text] [Related]
15. Significance of fluctuations in serum sodium levels following aneurysmal subarachnoid hemorrhage: an exploratory analysis. Eagles ME; Tso MK; Macdonald RL J Neurosurg; 2018 Aug; 131(2):420-425. PubMed ID: 30117765 [TBL] [Abstract][Full Text] [Related]
16. Analytic review: glucose controversies in the ICU. Honiden S; Inzucchi SE J Intensive Care Med; 2011; 26(3):135-50. PubMed ID: 21118863 [TBL] [Abstract][Full Text] [Related]
17. Are closed-loop systems for intensive insulin therapy ready for prime time in the ICU? Okabayashi T; Shima Y Curr Opin Clin Nutr Metab Care; 2014 Mar; 17(2):190-9. PubMed ID: 24378668 [TBL] [Abstract][Full Text] [Related]
18. The REACT study: design of a randomized phase 3 trial to assess the efficacy and safety of clazosentan for preventing deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Bruder N; Higashida R; Santin-Janin H; Dubois C; Aldrich EF; Marr A; Roux S; Mayer SA BMC Neurol; 2022 Dec; 22(1):492. PubMed ID: 36539711 [TBL] [Abstract][Full Text] [Related]
19. Hypoglycemia risk: a cause for concern in the intensive care unit hyperglycemia control debate. Freire AX; Avecillas JF; Yataco JC; Freire NE Crit Care Med; 2007 Apr; 35(4):1222; author reply 1222. PubMed ID: 17413809 [No Abstract] [Full Text] [Related]
20. Intensive insulin therapy in the intensive care unit, hypoglycemia, and cardiovascular mortality. Rana O; Byrne CD; Greaves K Hosp Pract (1995); 2010 Apr; 38(2):59-66. PubMed ID: 20469614 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]